{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T07:19:44Z","timestamp":1700551184443},"reference-count":18,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2012,1,17]],"date-time":"2012-01-17T00:00:00Z","timestamp":1326758400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Forum Allergy Rhinol"],"published-print":{"date-parts":[[2012,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background:<\/jats:title><jats:p>Topical intranasal corticosteroid sprays are a mainstay of treatment for nasal polyposis. Newer treatment strategies for refractory polypoid disease include \u201coff label\u201d topical steroids such as prednisolone acetate. This study investigates the safety of intranasal prednisolone acetate; evaluating its effect on serum cortisol and adrenocorticotropin hormone (ACTH) levels.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>This retrospective study included adult patients with refractory nasal polyposis, who had not taken oral steroids for 3 months prior to entry into the study. Patients applied 2 sprays of 1% prednisolone acetate delivered via a 15\u2010mL standardized spray bottle twice daily. Morning serum cortisol and ACTH levels were collected prior to treatment and 6 to 8 weeks posttreatment. Pretreatment and posttreatment values were compared.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Nine patients were included in this study. The average serum cortisol and ACTH levels prior to treatment was 12.09 \u03bcg\/dL (95% confidence interval [CI], 6.94\u201317.24) and 12.33 ng\/L (95% CI, 8.97\u201315.70), respectively. After 6 to 8 weeks of treatment, the average serum cortisol and ACTH levels were 11.76 \u03bcg\/dL (95% CI, 9.51\u201314.00) and 13.22 ng\/L (95% CI, 10.68\u201315.77), respectively. There was no statistically significant difference between pretreatment and posttreatment values for cortisol (<jats:italic>p<\/jats:italic> = 0.89) or ACTH (<jats:italic>p<\/jats:italic> = 0.63).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Intranasal delivery of prednisolone acetate, at the specified dose, does not result in suppression of the adrenal axis. It can be considered as a safe alternative for management of aggressive nasal polyposis refractory to traditional treatment strategies. \u00a9 2012 ARS\u2010AAOA, LLC.<\/jats:p><\/jats:sec>","DOI":"10.1002\/alr.21014","type":"journal-article","created":{"date-parts":[[2012,1,17]],"date-time":"2012-01-17T19:26:32Z","timestamp":1326828392000},"page":"126-129","source":"Crossref","is-referenced-by-count":3,"title":["Examining the safety of prednisolone acetate 1% nasal spray for treatment of nasal polyposis"],"prefix":"10.1002","volume":"2","author":[{"given":"Jonathan","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Bradley","family":"Strong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,1,17]]},"reference":[{"issue":"249","key":"e_1_2_6_2_2","first-page":"1","article-title":"Summary health statistics for U.S. adults: National Health Interview Survey, 2009","author":"Pleis JR","year":"2010","journal-title":"Vital Health Stat 10"},{"key":"e_1_2_6_3_2","first-page":"1","article-title":"Chronic rhinosinusitis patterns of illness","volume":"20","author":"Hamilos DL","year":"2007","journal-title":"Clin Allergy Immunol"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200161050-00003"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2008.05.628"},{"key":"e_1_2_6_6_2","first-page":"2","article-title":"Functional endoscopic sinus surgery: 5 year follow up and results of a prospective, randomized, stratified, double\u2010blind, placebo controlled study of postoperative fluticasone propionate aqueous nasal spray","volume":"43","author":"Rowe\u2010Jones JM","year":"2005","journal-title":"Rhinology"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215100104372"},{"key":"e_1_2_6_8_2","first-page":"49","article-title":"Flunisolide nasal spray 0.025% in the prophylactic treatment of nasal polyposis after polypectomy. A randomized, double blind, parallel, placebo controlled study","volume":"23","author":"Dingsor G","year":"1985","journal-title":"Rhinology"},{"key":"e_1_2_6_9_2","first-page":"144","article-title":"A randomized trial of intranasal beclomethasone dipropionate after polypectomy","volume":"20","author":"Karlsson G","year":"1982","journal-title":"Rhinology"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.2500\/ajra.2010.24.3418"},{"key":"e_1_2_6_11_2","first-page":"821","article-title":"Safety of budesonide in saline sinonasal irrigations in the management of chronic rhinosinusitis with polyposis: lack of significant adrenal suppression","volume":"37","author":"Bhalla RK","year":"2008","journal-title":"J Otolaryngology Head Neck Surg"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/archoto.2008.555"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.115564"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1159\/000216193"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/MLG.0b013e31817c0b4d"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1L546"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2009.07.001"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2003.10.001"},{"key":"e_1_2_6_19_2","first-page":"CD002310","article-title":"Inhaled fluticasone versus inhaled beclomethasone or inhaled budesonide for chronic asthma in adults and children","author":"Adams N","year":"2004","journal-title":"Cochrane Database Syst Rev"}],"container-title":["International Forum of Allergy &amp; Rhinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Falr.21014","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/alr.21014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T06:39:12Z","timestamp":1700548752000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/alr.21014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,17]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["10.1002\/alr.21014"],"URL":"https:\/\/doi.org\/10.1002\/alr.21014","archive":["Portico"],"relation":{},"ISSN":["2042-6976","2042-6984"],"issn-type":[{"value":"2042-6976","type":"print"},{"value":"2042-6984","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,17]]}}}